Form 4: HealthStream Inc. Executive Jeff Cunningham Reports Acquisition of Restricted Share Units
SEC Filing (Form 4)
HealthStream Inc.'s Chief Technology Officer, Jeff Cunningham, reports the acquisition of restricted share units (RSUs) in a recent SEC filing.
Summary
- Jeff Cunningham, Chief Technology Officer of HealthStream Inc., filed a Form 4 with the SEC.
- The filing reports the acquisition of 2,048 restricted share units (RSUs) on September 18, 2024.
- These RSUs represent the contingent right to receive one share of common stock upon vesting.
- The RSUs vest over a four-year schedule, contingent upon continued service.
- The vesting schedule is as follows: 15% on September 18, 2025, 20% on September 18, 2026, 30% on September 18, 2027, and 35% on September 18, 2028.
- Following the reported transaction, Cunningham directly holds 2,048 derivative securities and 25,281 shares of common stock.
Sentiment
Score: 7
Explanation: The sentiment is neutral to positive. The acquisition of RSUs is a standard practice and indicates confidence in the company's future performance. The vesting schedule promotes long-term commitment.
Positives
- The acquisition of RSUs aligns the executive's interests with the long-term performance of the company.
- The vesting schedule incentivizes continued service and commitment from the CTO.
Future Outlook
The vesting schedule of the RSUs extends to September 18, 2028, indicating a long-term incentive plan for the executive.
Industry Context
This filing is a routine disclosure of insider transactions, common in publicly traded companies to ensure transparency and prevent insider trading. It reflects standard compensation practices using equity-based incentives.
Comparison to Industry Standards
- Equity compensation, such as RSUs, is a common practice among publicly traded companies, especially in the technology sector, to align executive compensation with shareholder value.
- Companies like Cerner (now Oracle Health) and McKesson also utilize similar equity-based compensation plans for their executives.
- The vesting schedule of four years is fairly standard, aligning with typical long-term incentive programs.
Stakeholder Impact
- Shareholders may view the RSU grant positively as it aligns executive interests with company performance.
- Employees may see this as a positive sign of the company's commitment to its leadership.
Key Dates
| Date | Description |
|---|---|
| 09/18/2024 | Date of earliest transaction (acquisition of RSUs) |
| 09/18/2025 | 15% of RSUs vest |
| 09/18/2026 | 20% of RSUs vest |
| 09/18/2027 | 30% of RSUs vest |
| 09/18/2028 | 35% of RSUs vest |
| 09/20/2024 | Date of signature on the Form 4 |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.